These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2016931)

  • 21. [The basic treatment of arterial hypertension (II). Pharmacological treatment].
    Pascual J; Orte L; Ortuño J
    Med Clin (Barc); 1994 Nov; 103(18):699-707. PubMed ID: 7808078
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of drug cost on hypertension treatment decision.
    Salman H; Bergman M; Hart J; Neuman V; Zevin D; Bessler H; Djaldetti M
    Public Health; 1999 Sep; 113(5):243-6. PubMed ID: 10557119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The costs of antihypertensive therapy.
    Kaplan NM
    Arch Intern Med; 1996 Jan; 156(1):110-1. PubMed ID: 8526689
    [No Abstract]   [Full Text] [Related]  

  • 24. Public health value of fixed-dose combinations in hypertension.
    Ruilope LM; Burnier M; Muszbek N; Brown RE; Keskinaslan A; Ferber P; Harms G
    Blood Press Suppl; 2008 Jun; 1():5-14. PubMed ID: 18705530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Economy, costs and drug choices in cardiology. A reflection on the 2012 position paper of the Italian Society of Hypertension].
    Camerini F; Palcic S
    G Ital Cardiol (Rome); 2013 Jun; 14(6):412-5. PubMed ID: 23748537
    [No Abstract]   [Full Text] [Related]  

  • 26. Is more always better?
    Tuulonen A
    Acta Ophthalmol Scand; 2004 Aug; 82(4):377-9. PubMed ID: 15291927
    [No Abstract]   [Full Text] [Related]  

  • 27. Variability in antihypertensive drug costs.
    Chandler M; Hoogland GA
    N Z Med J; 1989 Sep; 102(875):482. PubMed ID: 2779912
    [No Abstract]   [Full Text] [Related]  

  • 28. A retrospective analysis comparing the costs and cost effectiveness of amlodipine and enalapril in the treatment of hypertension.
    Doyle J; Omvik P; Arikian S; Casciano J; Casciano R; Gonzalez MA; Arocho R
    Manag Care Interface; 2001 Mar; 14(3):82-7. PubMed ID: 11301961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The comparative assessment of the efficacy of hypotensive preparations in stage-II hypertension].
    Tiurin VP; Fursov AN; Gospodarenko AL; Liapkova NB; Orlov FA
    Voen Med Zh; 1997 Nov; 318(11):46-7. PubMed ID: 9461836
    [No Abstract]   [Full Text] [Related]  

  • 30. Angiotensin receptor blockers: impact on costs of care.
    Am J Manag Care; 2005 Nov; 11(13 Suppl):S400-3. PubMed ID: 16300456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacoeconomics of hypertension control: basic principles of economic evaluation.
    Wilson TW; Chockalingam A; Quest DW
    J Hum Hypertens; 1996 Feb; 10 Suppl 2():S19-22. PubMed ID: 8868039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of mandatory prescribing of thiazides for newly treated, uncomplicated hypertension: interrupted time-series analysis.
    Fretheim A; Håvelsrud K; MacLennan G; Kristoffersen DT; Oxman AD
    PLoS Med; 2007 Jul; 4(7):e232. PubMed ID: 17622192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in hypertensive drug costs.
    Kawachi I; Malcolm L; Purdie G
    N Z Med J; 1989 Sep; 102(876):516-7. PubMed ID: 2797583
    [No Abstract]   [Full Text] [Related]  

  • 34. Trends in antihypertensive medication costs in a cohort of Aucklanders 1982-87.
    Sinclair BL; Ashton T; Jackson R; Beaglehole R
    N Z Med J; 1989 Oct; 102(877):521-3. PubMed ID: 2797584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cost of the treatments of arterial hypertension associated with diabetes].
    Passa P; Giraud S
    Diabete Metab; 1993 Dec; 19(5 Suppl):523-7. PubMed ID: 8206192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Between-country variation in the utilization of antihypertensive agents: Guidelines and clinical practice.
    Stolk P; Van Wijk BL; Leufkens HG; Heerdink ER
    J Hum Hypertens; 2006 Dec; 20(12):917-22. PubMed ID: 16988753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economics of hypertension control.
    Fletcher A
    J Med Liban; 1994; 42(3):138-44. PubMed ID: 7629847
    [No Abstract]   [Full Text] [Related]  

  • 38. Health economic issues and the future treatment and management of hypertension.
    Giles TD
    AAPPO J; 1994; 4(4):27-8, 30, 33-5. PubMed ID: 10150589
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypertension therapy--never without diuretics?].
    Anlauf M
    MMW Fortschr Med; 2007 Nov; 149(46):31-3. PubMed ID: 18069189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive drug prescribing in Grampian.
    Ross S; Macleod MJ
    Br J Clin Pharmacol; 2005 Sep; 60(3):300-5. PubMed ID: 16120069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.